Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort
Introduction: Totally implantable venous access devices (TIVADs) or ports are increasingly used in oncology settings to provide long-term, easy venous access. This study reports our experience and results with 1180 cases in Singapore. Method: Data from January 2019 to January 2022, obtained from a...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Medicine Singapore
2025-01-01
|
Series: | Annals, Academy of Medicine, Singapore |
Online Access: | https://annals.edu.sg/radiologic-placement-of-totally-implantable-venous-access-devices-outcomes-and-complications-from-a-large-oncology-cohort/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832544259323985920 |
---|---|
author | Sonam Tashi Alfred Bingchao Tan Jasmine Ming Er Chua Gek Hsiang Lim Nanda Venkatanarasimha Sivanathan Chandramohan |
author_facet | Sonam Tashi Alfred Bingchao Tan Jasmine Ming Er Chua Gek Hsiang Lim Nanda Venkatanarasimha Sivanathan Chandramohan |
author_sort | Sonam Tashi |
collection | DOAJ |
description |
Introduction: Totally implantable venous access devices (TIVADs) or ports are increasingly used in oncology settings to provide long-term, easy venous access. This study reports our experience and results with 1180 cases in Singapore. Method: Data from January 2019 to January 2022, obtained from a hospital-approved secure database application called the Research Electronic Data Capture registry, were reviewed and analysed retrospectively. Results: A total of 1180 patients underwent TIVAD implantation with a 100% technical success rate. The mean age of the cohort was 61.9 years. The mean dwell duration was 342 days (standard deviation [SD] 223; range 3–1911). By 1 February 2022, 83% of patients were still using the TIVAD, 13.6 % underwent removal after completion of treatment, 2.1% were removed due to infection, 0.6% due to malfunction, 0.6% due to port extrusion and 0.1% at patient’s request. The right internal jugular vein (IJV) was the most commonly accessed site (83.6%), followed by the left IJV (15.6%). The early post-procedure complications were pain (24.7%), bruising (9.2%), swelling (3.6%), bleeding (0.5%), fever (0.4%), itchiness (0.2%) and allergic dermatitis (0.1%). The delayed post-procedure complications were TIVAD site cellulitis (3.80%); discharge (1.10%); skin erosion with device extrusion (0.60%); malpositioned catheter (0.33%), which was successfully repositioned, catheter-related bloodstream infections (0.25%); migration of TIVAD leading to catheter dislodgement (0.25%); venous thrombosis (0.25%); fibrin sheath formation requiring stripping (0.10%) and TIVAD chamber inversion (0.10%). Conclusion: TIVAD implantation via the jugular vein under radiological guidance provides a safe, reliable and convenient means of long-term venous access in oncology patients. By sharing our experience and acceptable outcomes from a large oncology cohort, we aim to increase the awareness and adoption of TIVAD usage in oncology patients, especially in Asia. |
format | Article |
id | doaj-art-3f9e296d43a14f53b9978bfb76a80e8b |
institution | Kabale University |
issn | 2972-4066 |
language | English |
publishDate | 2025-01-01 |
publisher | Academy of Medicine Singapore |
record_format | Article |
series | Annals, Academy of Medicine, Singapore |
spelling | doaj-art-3f9e296d43a14f53b9978bfb76a80e8b2025-02-03T10:39:53ZengAcademy of Medicine SingaporeAnnals, Academy of Medicine, Singapore2972-40662025-01-01541273510.47102/annals-acadmedsg.2024166Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohortSonam TashiAlfred Bingchao TanJasmine Ming Er ChuaGek Hsiang LimNanda VenkatanarasimhaSivanathan Chandramohan Introduction: Totally implantable venous access devices (TIVADs) or ports are increasingly used in oncology settings to provide long-term, easy venous access. This study reports our experience and results with 1180 cases in Singapore. Method: Data from January 2019 to January 2022, obtained from a hospital-approved secure database application called the Research Electronic Data Capture registry, were reviewed and analysed retrospectively. Results: A total of 1180 patients underwent TIVAD implantation with a 100% technical success rate. The mean age of the cohort was 61.9 years. The mean dwell duration was 342 days (standard deviation [SD] 223; range 3–1911). By 1 February 2022, 83% of patients were still using the TIVAD, 13.6 % underwent removal after completion of treatment, 2.1% were removed due to infection, 0.6% due to malfunction, 0.6% due to port extrusion and 0.1% at patient’s request. The right internal jugular vein (IJV) was the most commonly accessed site (83.6%), followed by the left IJV (15.6%). The early post-procedure complications were pain (24.7%), bruising (9.2%), swelling (3.6%), bleeding (0.5%), fever (0.4%), itchiness (0.2%) and allergic dermatitis (0.1%). The delayed post-procedure complications were TIVAD site cellulitis (3.80%); discharge (1.10%); skin erosion with device extrusion (0.60%); malpositioned catheter (0.33%), which was successfully repositioned, catheter-related bloodstream infections (0.25%); migration of TIVAD leading to catheter dislodgement (0.25%); venous thrombosis (0.25%); fibrin sheath formation requiring stripping (0.10%) and TIVAD chamber inversion (0.10%). Conclusion: TIVAD implantation via the jugular vein under radiological guidance provides a safe, reliable and convenient means of long-term venous access in oncology patients. By sharing our experience and acceptable outcomes from a large oncology cohort, we aim to increase the awareness and adoption of TIVAD usage in oncology patients, especially in Asia.https://annals.edu.sg/radiologic-placement-of-totally-implantable-venous-access-devices-outcomes-and-complications-from-a-large-oncology-cohort/ |
spellingShingle | Sonam Tashi Alfred Bingchao Tan Jasmine Ming Er Chua Gek Hsiang Lim Nanda Venkatanarasimha Sivanathan Chandramohan Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort Annals, Academy of Medicine, Singapore |
title | Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort |
title_full | Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort |
title_fullStr | Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort |
title_full_unstemmed | Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort |
title_short | Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort |
title_sort | radiologic placement of totally implantable venous access devices outcomes and complications from a large oncology cohort |
url | https://annals.edu.sg/radiologic-placement-of-totally-implantable-venous-access-devices-outcomes-and-complications-from-a-large-oncology-cohort/ |
work_keys_str_mv | AT sonamtashi radiologicplacementoftotallyimplantablevenousaccessdevicesoutcomesandcomplicationsfromalargeoncologycohort AT alfredbingchaotan radiologicplacementoftotallyimplantablevenousaccessdevicesoutcomesandcomplicationsfromalargeoncologycohort AT jasminemingerchua radiologicplacementoftotallyimplantablevenousaccessdevicesoutcomesandcomplicationsfromalargeoncologycohort AT gekhsianglim radiologicplacementoftotallyimplantablevenousaccessdevicesoutcomesandcomplicationsfromalargeoncologycohort AT nandavenkatanarasimha radiologicplacementoftotallyimplantablevenousaccessdevicesoutcomesandcomplicationsfromalargeoncologycohort AT sivanathanchandramohan radiologicplacementoftotallyimplantablevenousaccessdevicesoutcomesandcomplicationsfromalargeoncologycohort |